These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 36987424)
1. Association between Genetic Polymorphism of Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283 [No Abstract] [Full Text] [Related]
2. The possible effect of SCN1A and SCN2A genetic variants on carbamazepine response among Khyber Pakhtunkhwa epileptic patients, Pakistan. Nazish HR; Ali N; Ullah S Ther Clin Risk Manag; 2018; 14():2305-2313. PubMed ID: 30538486 [TBL] [Abstract][Full Text] [Related]
3. Effects of GRM4, SCN2A and SCN3B polymorphisms on antiepileptic drugs responsiveness and epilepsy susceptibility. Al-Eitan LN; Al-Dalalah IM; Aljamal HA Saudi Pharm J; 2019 Jul; 27(5):731-737. PubMed ID: 31297029 [TBL] [Abstract][Full Text] [Related]
4. Bryson A; Petrou S Front Neurol; 2023; 14():1173460. PubMed ID: 37139072 [TBL] [Abstract][Full Text] [Related]
5. Deciphering the Complexities of Sodium Voltage-Gated Channel Alpha Subunit 1 (SCN1A) Mutation: A Case of Intractable Epilepsy in a Five-and-a-Half-Month-Old Male. Jadhav I; Vagha K; Varma A; Vagha JD; Lath YV; Jadhav J Cureus; 2024 Jul; 16(7):e64171. PubMed ID: 39119390 [TBL] [Abstract][Full Text] [Related]
6. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis. Zhang X; Liu J; Ye J Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in SCN2A are not associated with epilepsy risk and AEDs response: evidence from a meta-analysis. Yang R; Qian R; Chen K; Yi W; Sima X Neurol Sci; 2021 Jul; 42(7):2705-2711. PubMed ID: 33914194 [TBL] [Abstract][Full Text] [Related]
8. SCN1A polymorphisms influence the antiepileptic drugs responsiveness in Jordanian epileptic patients. Abduljabbar R; Eid TD; Yousef AM; Mukred SR; Zawiah M J Med Biochem; 2023 Mar; 42(2):214-223. PubMed ID: 36987424 [TBL] [Abstract][Full Text] [Related]
9. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis. Bao Y; Liu X; Xiao Z Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177 [TBL] [Abstract][Full Text] [Related]
10. Association Between Li M; Zhong R; Lu Y; Zhao Q; Li G; Lin W Front Neurol; 2020; 11():591828. PubMed ID: 33519675 [No Abstract] [Full Text] [Related]
11. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis. Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570 [TBL] [Abstract][Full Text] [Related]
12. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients. Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367 [TBL] [Abstract][Full Text] [Related]
13. Single-Base Gene Variants in Buainain RP; Sodré AR; Dos Santos JS; Takazaki KAG; Queiroz LS; de Oliveira CTP; de Aguiar PHP; Marson FAL; Ortega MM Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892194 [TBL] [Abstract][Full Text] [Related]
14. Identification of serum miR-378 and miR-575 as diagnostic indicators and predicting surgical prognosis in human epilepsy. Li X; Gao Z; Ma ML; Li L; Guo S J Med Biochem; 2022 Apr; 41(2):184-190. PubMed ID: 35510204 [TBL] [Abstract][Full Text] [Related]